Innoviva (INVA) Net Income (2010 - 2026)
Innoviva (INVA) reported Net Income of -$83.42 million for Q2 2026, compared with $63.69 million a year earlier.
Powered by 
Analysis
Innoviva (INVA) Net Income (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Innoviva's Net Income came in at $357.24 million, up 824.3% year-over-year; for FY2025, it was $271.17 million.
- Net Income has a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
- By year, Net Income came in at $23.39 million in FY2024 (-87.0%), $179.72 million in FY2023 (-18.4%), $220.26 million in FY2022 (-40.3%) and $368.84 million in FY2021 (+25.5%).
- The Q2 2026 figure ranks as the lowest quarterly Net Income in data going back to Q2 2010.
- The high point for year-over-year Net Income in five years was Q4 2025 (growth of 707.4%); the low point was Q2 2023 (a decline of 94.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $186.6 million (Q1 2026), $164.15 million (Q4 2025) and $89.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Innoviva | 1.54 Bn | -750.13 Mn | 90.62 Mn | -83.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -83.42 Mn |
| Mar 31, 2026 | 186.60 Mn |
| Dec 31, 2025 | 164.15 Mn |
| Sep 30, 2025 | 89.91 Mn |
| Jun 30, 2025 | 63.69 Mn |
| Mar 31, 2025 | -46.58 Mn |
| Dec 31, 2024 | 20.33 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | -34.69 Mn |
| Mar 31, 2024 | 36.53 Mn |
| Sep 30, 2023 | 82.05 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 34.87 Mn |
| Dec 31, 2022 | -10.33 Mn |
| Sep 30, 2022 | 229.35 Mn |
| Jun 30, 2022 | 21.37 Mn |
| Mar 31, 2022 | 37.86 Mn |
| Dec 31, 2021 | 45.65 Mn |
| Sep 30, 2021 | 102.65 Mn |
| Jun 30, 2021 | 110.85 Mn |
API Access
Innoviva Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();